Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 3, 2015, Pages 446-454

  Wu, N ^a   Li, W N ^a   Shu, W Q ^a   Lv, Y ^a   Jia, D L ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cyclosporine A; Hypercholesterolemia; Ischemic postconditioning; Mitochondrial permeability transition pore

Indexed keywords

CREATINE KINASE MB; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TRIPHENYLTETRAZOLIUM; CARRIER PROTEIN; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEMODYNAMIC MONITORING; HYPERCHOLESTEROLEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; CYCLOSPORINE; HYPERCHOLESTEROLEMIA; ISCHEMIC POSTCONDITIONING; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL ISCHEMIA; RATS; RATS, WISTAR;

EID: 84938954516     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ZHAO ZQ, CORVERA JS, HALKOS ME, KERENDI F, WANG N P, GUYTON RA, VINTEN-JOHANSEN J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion comparision with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:579-588.
2. SCHWARTZ LM, LAGRANHA CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 2006;290:1011-1018.
3. GROSS GJ, GAUTHIER KM, MOORE J, CAMPBELL WB, FALCK JR, NITHIPATIKOM K. Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog. Am J Physiol Heart Circ Physiol 2009;297:47-52.
4. STAAT P, RIOUFOL G, PIOT C, COTTIN Y, CUNG TT, L'HUILLIER I, AUPETIT J F, BONNEFOY E, FINET G, ANDRE-FOUET X, OVIZE M. Postconditioning the human heart. Circulation 2005;112:2143-2148.
5. ILIODROMITIS EK, ZOGA A, VRETTOU A, ANDREADOU I, PARASKEVAIDIS IA, KAKLAMANIS L, KREMASTINOS DT. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006;188:356-362.
6. ZHAO JL, YANG SJ, YOU SJ, CUI CJ, GAO RL. Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic miniswines. Microvasc Res 2007;73:137-142.
7. KUPAI K, CSONKA C, FEKETE V, ODENDAAL L, VAN ROOYEN J, MARAIS DE W, CSONT T, FERDINANDY P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 2009;297:1729-1735.
8. LAUZIER B, DELEMASURE S, PESANT M, COLLIN B, DUVILLARD L, VERGELY C, CONNAT JL, ROCHETTE L. A cholesterol-rich diet improves resistance to ischemic insult in mouse hearts but suppresses the beneficial effect of post-conditioning. J Heart Lung Transplant 2009;297:1729-1735.
9. CROMPTON M, COSTI A. Evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. a potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem 1988;178:489-501.
10. GRIFFITHS EJ, HALESTRAP AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307:93-98.
11. SHEU JJ, CHUA S, SUN CK, CHANG LT, YEN CH, WU CJ, FU M, YIP HK. Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction. Int J Cardiol 2011;147:79-87.
12. ARGAUD L, GATEAU-ROESCH O, MUNTEAN D, CHALABREYSSE L, LOUFOUAT J, ROBERT D, OVIZE M. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367-374.
13. YADAV HN, SINGH M, SHARMA PL. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. Eur J Pharmacol 2010;643:78-83.
14. ZHAO H, WANG Y, WU Y, LI X, YANG G, MA X, ZHAO R, LIU H. Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1a upregulation. Acta Biochim Biophys Sin 2009;41:745-753.
15. REN Y, CAI Y, JIA D. Comparative antiapoptotic effects of KB-R7943 and ischemic postconditioning during myocardial ischemia reperfusion. Cell Biochem Biophys 2012;64:137-145.
16. BYRNE CJ, MCCAFFERTY K, KIESWISH J, HARWOOD S, ANDRIKOPOULOS P, RAFTERY M, THIEMERMANN C, YAQOOB MM. Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction. Circulation 2012;125:1256-1265.
17. FERDINANDY P, SCHULZ R, BAXTER GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postcononditioning. Pharmacol Rev 2007;59:418-458.
18. DONATO M, D'ANNUNZIO V, BERG G, GONZALEZ G, SCHREIER L, MORALES C, WIKINSKI RL, GELP I RJ. Ischemic postconditioning reduces infarct size by activation of A1 receptors and KATP channels in both normal and hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2007;49:287-292.
19. ILIODROMITIS EK, ANDREADOU I, PROKOVAS E, ZOGA A, FARMAKIS D, FOTOPOULOU T, IOANNIDIS K, PARASKEVAIDIS IA, KREMSTINOS DT. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol 2010;105:193-203.
20. ANDREADOU I, FARMAKIS D, PROKOVAS E, SIGALA F, ZOGA A, SPYRIDAKI K, PAPALOIS A, PAPAPETROPOULOS A, ANASTASIOU-NANA M, KREMASTINOS DT, ILIODROMITIS EK. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Cardiovasc Res 2012;94:501-509.
21. CROMPTON M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341:233-249.
22. GATEAU ROESCH O, ARGAUD L, OVIZE M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006;70:264-273.
23. FREIXA X, BELLERA N, ORTIZ-PEREZ JT, JIMENEZ M, PARE C, BOSCH X, DE CARALT TM, BETRIU A, MASOTTI M. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012;33:103-112.
24. TARANTINI G, FAVARETTO E, MARRA M P, FRIGO AC, NAPODANO M, CACCIAVILLANI L, GIOVAGNONI A, RENDA P, DE BIASIO V, PLEBANI M, MION M, ZANINOTTO M, ISABELLA G, BILATO C, ILICETO S. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol 2012;162:33-38.
25. PENNA C, TULLIO F, MORO F, FOLINO A, MERLINO A, PAGLIARO P. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol 2010;105:181-192.
26. REN JY, SONG JX, LU MY, CHEN H. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P. Regul Pept 2011;169:49-57.